The role of taxanes in triple-negative breast cancer: literature review

por Mustacchi, Giorgio, De Laurentiis, Michelino
Publicado no Drug Des Devel Ther (2015)

Long Non-Coding RNA HOTAIR in Breast Cancer Therapy

por Cantile, Monica, Di Bonito, Maurizio, Cerrone, Margherita, Collina, Francesca, De Laurentiis, Michelino, Botti, Gerardo
Publicado no Cancers (Basel) (2020)

A meta-analytic review of the relationship of cancer coping self-efficacy with distress and quality of life

por Chirico, Andrea, Lucidi, Fabio, Merluzzi, Thomas, Alivernini, Fabio, De Laurentiis, Michelino, Botti, Gerardo, Giordano, Antonio
Publicado no Oncotarget (2017)

Active lifestyles in older adults: an integrated predictive model of physical activity and exercise

por Galli, Federica, Chirico, Andrea, Mallia, Luca, Girelli, Laura, De Laurentiis, Michelino, Lucidi, Fabio, Giordano, Antonio, Botti, Gerardo
Publicado no Oncotarget (2018)

LncRNA HOTAIR up-regulation is strongly related with lymph nodes metastasis and LAR subtype of Triple Negative Breast Cancer

por Collina, Francesca, Aquino, Gabriella, Brogna, Marianna, Cipolletta, Sabrina, Buonfanti, Gaetano, De Laurentiis, Michelino, Di Bonito, Maurizio, Cantile, Monica, Botti, Gerardo
Publicado no J Cancer (2019)

Triple-Negative Breast Cancer Comparison With Canine Mammary Tumors From Light Microscopy to Molecular Pathology

por Amirkhani Namagerdi, Asadoor, d’Angelo, Danila, Ciani, Francesca, Iannuzzi, Carmelina Antonella, Napolitano, Francesco, Avallone, Luigi, De Laurentiis, Michelino, Giordano, Antonio
Publicado no Front Oncol (2020)

Prognostic Value of Cancer Stem Cells Markers in Triple-Negative Breast Cancer

por Collina, Francesca, Di Bonito, Maurizio, Li Bergolis, Valeria, De Laurentiis, Michelino, Vitagliano, Carlo, Cerrone, Margherita, Nuzzo, Francesco, Cantile, Monica, Botti, Gerardo
Publicado no Biomed Res Int (2015)

Biomarkers in Triple-Negative Breast Cancer: State-of-the-Art and Future Perspectives

por Cocco, Stefania, Piezzo, Michela, Calabrese, Alessandra, Cianniello, Daniela, Caputo, Roberta, Di Lauro, Vincenzo, Fusco, Giuseppina, di Gioia, Germira, Licenziato, Marina, de Laurentiis, Michelino
Publicado no Int J Mol Sci (2020)

Adjuvant Subcutaneous Trastuzumab for HER2‐Positive Early Breast Cancer: Subgroup Analyses of Safety and Active Medical Conditions by Body Weight in the SafeHer Phase III Study

por Jung, Kyung Hae, Ataseven, Beyhan, Verrill, Mark, Pivot, Xavier, De Laurentiis, Michelino, Al‐Sakaff, Nedal, Lauer, Sabine, Shing, Mona, Gligorov, Joseph, Azim, Hamdy A.
Publicado no Oncologist (2018)

NLRP3 as Putative Marker of Ipilimumab-Induced Cardiotoxicity in the Presence of Hyperglycemia in Estrogen-Responsive and Triple-Negative Breast Cancer Cells

por Quagliariello, Vincenzo, De Laurentiis, Michelino, Cocco, Stefania, Rea, Giuseppina, Bonelli, Annamaria, Caronna, Antonietta, Lombari, Maria Cristina, Conforti, Gabriele, Berretta, Massimiliano, Botti, Gerardo, Maurea, Nicola
Publicado no Int J Mol Sci (2020)

Programmed Death Ligand 1 (PD-L1) Tumor Expression Is Associated with a Better Prognosis and Diabetic Disease in Triple Negative Breast Cancer Patients

por Botti, Gerardo, Collina, Francesca, Scognamiglio, Giosuè, Rao, Federica, Peluso, Valentina, De Cecio, Rossella, Piezzo, Michela, Landi, Gabriella, De Laurentiis, Michelino, Cantile, Monica, Di Bonito, Maurizio
Publicado no Int J Mol Sci (2017)

An Italian Delphi study to evaluate consensus on adjuvant endocrine therapy in premenopausal patients with breast cancer: the ERA project

por Pelizzari, Giacomo, Arpino, Grazia, Biganzoli, Laura, Cinieri, Saverio, De Laurentiis, Michelino, Del Mastro, Lucia, Di Leo, Angelo, Gori, Stefania, Guarneri, Valentina, Marchetti, Paolo, Puglisi, Fabio
Publicado no BMC Cancer (2018)

Targeting Autophagy in Breast Cancer

por Cocco, Stefania, Leone, Alessandra, Piezzo, Michela, Caputo, Roberta, Di Lauro, Vincenzo, Di Rella, Francesca, Fusco, Giuseppina, Capozzi, Monica, Gioia, Germira di, Budillon, Alfredo, De Laurentiis, Michelino
Publicado no Int J Mol Sci (2020)

The SGLT-2 inhibitor empagliflozin improves myocardial strain, reduces cardiac fibrosis and pro-inflammatory cytokines in non-diabetic mice treated with doxorubicin

por Quagliariello, Vincenzo, De Laurentiis, Michelino, Rea, Domenica, Barbieri, Antonio, Monti, Maria Gaia, Carbone, Andreina, Paccone, Andrea, Altucci, Lucia, Conte, Mariarosaria, Canale, Maria Laura, Botti, Gerardo, Maurea, Nicola
Publicado no Cardiovasc Diabetol (2021)

CDK 4/6 Inhibitors as Single Agent in Advanced Solid Tumors

por Schettini, Francesco, De Santo, Irene, Rea, Carmen G., De Placido, Pietro, Formisano, Luigi, Giuliano, Mario, Arpino, Grazia, De Laurentiis, Michelino, Puglisi, Fabio, De Placido, Sabino, Del Mastro, Lucia
Publicado no Front Oncol (2018)

Body mass index and treatment outcomes following neoadjuvant therapy in women aged 45 y or younger: Evidence from a historic cohort

por D'Aiuto, Massimiliano, Chirico, Andrea, De Riggi, Michele Antonio, Frasci, Giuseppe, De Laurentiis, Michelino, Di Bonito, Maurizio, Vici, Patrizia, Pizzuti, Laura, Sergi, Domenico, Maugeri-Saccà, Marcello, Barba, Maddalena, Giordano, Antonio
Publicado no Cancer Biol Ther (2016)

A Psychosocial Genomics Pilot Study in Oncology for Verifying Clinical, Inflammatory and Psychological Effects of Mind-Body Transformations-Therapy (MBT-T) in Breast Cancer Patient...

por Cozzolino, Mauro, Cocco, Stefania, Piezzo, Michela, Celia, Giovanna, Costantini, Susan, Abate, Valentina, Capone, Francesca, Barberio, Daniela, Girelli, Laura, Cavicchiolo, Elisa, Ascierto, Paolo Antonio, Madonna, Gabriele, Budillon, Alfredo, De Laurentiis, Michelino
Publicado no J Clin Med (2021)

Molecular profiles of screen detected vs. symptomatic breast cancer and their impact on survival: results from a clinical series

por Crispo, Anna, Barba, Maddalena, D’Aiuto, Giuseppe, De Laurentiis, Michelino, Grimaldi, Maria, Rinaldo, Massimo, Caolo, Giuseppina, D’Aiuto, Massimiliano, Capasso, Immacolata, Esposito, Emanuela, Amore, Alfonso, Di Bonito, Maurizio, Botti, Gerardo, Montella, Maurizio
Publicado em 2013

Luminal-like HER2-negative stage IA breast cancer: a multicenter retrospective study on long-term outcome with propensity score analysis

por De Angelis, Carmine, Di Maio, Massimo, Crispo, Anna, Giuliano, Mario, Schettini, Francesco, Bonotto, Marta, Gerratana, Lorenzo, Iacono, Donatella, Cinausero, Marika, Riccardi, Ferdinando, Ciancia, Giuseppe, De Laurentiis, Michelino, Puglisi, Fabio, De Placido, Sabino, Arpino, Grazia
Publicado no Oncotarget (2017)

Uptake of Trastuzumab Biosimilars for the Treatment of HER2-Positive Breast Cancer: A Real-World Experience from a Cancer Center

por Piezzo, Michela, D’Aniello, Roberta, Avallone, Ilaria, Barba, Bruno, Cianniello, Daniela, Cocco, Stefania, D’Avino, Antonio, Di Gioia, Germira, Di Lauro, Vincenzo, Fusco, Giuseppina, Piscitelli, Raffaele, von Arx, Claudia, De Laurentiis, Michelino, Maiolino, Piera
Publicado no Pharmaceutics (2021)